Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | GLI1 | P08151 | 1/20 | 0.56 |
| ▸ | GLI2 | P10070 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Humulone SCHEMBL30712204 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL157914 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL31668762 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL29422612 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL23460398 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL17629686 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL23781774 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL30712205 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| SCHEMBL29356602 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL4211645 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7303 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514146-B1 | A COMBINATION FOR USE IN THE PREPARATION OF A DRINKABLE FOAMING OR FOAMABLE LIQUID, A DEVICE AND A METHOD FOR PREPARING AND DISPENSING A DRINKABLE FOAMING OR FOAMABLE LIQUID | BAR ON B V (BE) | 2026-05-13 | — | — | EP | claimed |
| US-20260124219-A1 | CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION | SRIN THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | claimed |
| US-20260102358-A1 | METHODS FOR MAINTAINING CONCENTRATIONS OF VOLATILE LIPOPHILIC COMPOUNDS IN MANUFACTURE OF COMPOSITIONS AND DOSAGE FORMS | CURIO IP LLC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4721579-A1 | BEER-FLAVOURED NON-ALCOHOLIC BEVERAGES AND METHODS OF MAKING | MFG Capital GmbH (DE) | 2026-04-08 | — | — | EP | claimed |
| EP-4709354-A1 | CANNABINOID-BASED FORMULATION | MRX Medical Limited (GB) | 2026-03-18 | — | — | EP | claimed |
| EP-4709355-A1 | CANNABINOID-BASED FORMULATION | MRX Medical Limited (GB) | 2026-03-18 | — | — | EP | claimed |
| US-20260069613-A1 | CANNABINOID AND TERPENE COMPOSITION TO BE APPLIED ON AN ABSORBENT MATERIAL. | TRIBU HEMP LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705494-A1 | METHODS FOR THE PRODUCTION AND RECOVERY OF VOLATILE MOLECULES | Amyris, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| US-12569433-B2 | Microemulsion delivery systems for water-based beverages | Quicksilver Scientific, Inc. (US) | 2026-03-10 | — | — | US | claimed |
| US-12568982-B2 | Systems for retaining potency in an infused beverage | VERTOSA INC. (US) | 2026-03-10 | — | — | US | claimed |
| WO-2002053138-A2 | TREATMENT FOR INHIBITING NEOPLASTIC LESIONS USING INCENSOLE AND/OR FURANOGERMACRENS | SHANAHAN-PRENDERGAST ELISABETH (IE) | 2002-07-11 | — | — | WO | claimed |
| US-20020076475-A1 | Isomerized alpha-acids containing composition is added to wort during brewing, composition comprises mixture of alkali metal salts of reduced (rho-) iso-alpha-acids, beta-acids, hop oil and water | JPMORGAN CHASE BANK, N.A. | 2002-06-20 | — | — | US | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| EP-1183089-A1 | REDUCTION OF OZONE IN AN ENCLOSED ENVIRONMENT | Atmospheric Solutions Limited (GB) | 2002-03-06 | — | — | EP | claimed |
| WO-2002002497-A1 | RHO-ISOALPHA ACID HOP PRODUCTS AND METHODS | S.S. STEINER, INC. (US) | 2002-01-10 | — | — | WO | claimed |
| WO-2000074820-A1 | REDUCTION OF OZONE IN AN ENCLOSED ENVIRONMENT | ATMOSPHERIC SOLUTIONS LIMITED (GB) | 2000-12-14 | — | — | WO | claimed |
| US-6063383-A | Pharmaceutical suppository composites for fever and influenza and method of producing the composites | HSU WU-CHING (TW) | 2000-05-16 | — | — | US | claimed |
| US-5314693-A | Hydroxystilbene compounds | KIORITZ CORPORATION (JP) | 1994-05-24 | — | — | US | claimed |
| EP-0583315-A1 | USE OF TERPENOID COMPOUNDS IN AGRICULTURE OR HORTICULTURE AND FOR PREPARING PREPARATIONS FOR CONTROLLING WHITEFLY SPECIES | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1994-02-23 | — | — | EP | claimed |
| WO-1992018001-A1 | USE OF TERPENOID COMPOUNDS IN AGRICULTURE OR HORTICULTURE AND FOR PREPARING PREPARATIONS FOR CONTROLLING WHITEFLY SPECIES | NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) | 1992-10-29 | — | — | WO | claimed |